Immortalized nanodendritic cells decorated with immune-checkpoint inhibitors for personalized cancer immunotherapy
- 27 March 2024
- journal article
- research article
- Published by Elsevier in Nano Today
- Vol. 56, 102237
Abstract
No abstract availableKeywords
Funding Information
- Korea Ministry of Health and Welfare
- Korea Drug Development Fund
- NRF
This publication has 43 references indexed in Scilit:
- Aggregation‐Induced‐Emission Photosensitizer‐Loaded Nano‐Superartificial Dendritic Cells with Directly Presenting Tumor Antigens and Reversed Immunosuppression for Photodynamically Boosted ImmunotherapyAdvanced Materials, 2022
- Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor ImmunityAdvanced Materials, 2022
- A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer ImmunotherapyAdvanced Materials, 2022
- Photoactivatable Silencing Extracellular Vesicle (PASEV) Sensitizes Cancer ImmunotherapyAdvanced Materials, 2022
- Advancing to the era of cancer immunotherapyCancer Communications, 2021
- Cancer Cell Membrane‐Coated Nanoparticles for Personalized Therapy in Patient‐Derived Xenograft ModelsAdvanced Functional Materials, 2019
- Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle FunctionalizationAdvanced Materials, 2017
- Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanismsEuropean Journal of Immunology, 2011
- Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer DrugsSmall, 2007
- Dendritic cells as mediators of tumor-induced tolerance in metastatic melanomaInternational Journal of Cancer, 1997